|
1
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Radmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lai EC: Micro RNAs are complementary to
3′UTR sequence motifs that mediate negative post-transcriptional
regulation. Nat Genet. 30:363–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shim J and Nam JW: The expression and
functional roles of microRNAs in stem cell differentiation. BMB
Rep. 49:3–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu C, Xu Y, Zhang S, Guan H, Song S, Wang
X, Wang Y, Li Y and Zhao G: miR-27a attenuates adipogenesis and
promotes osteogenesis in steroid-induced rat BMSCs by targeting
PPARγ and GREM1. Sci Rep. 6:384912016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Zhang S, Xu Y, Zhang Y, Guan H, Li
X, Li Y and Wang Y: Upregulation of miR-192 inhibits cell growth
and invasion and induces cell apoptosis by targeting TCF7 in human
osteosarcoma. Tumour Biol. 37:15211–15220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yi Y, Chen J, Jiao C, Zhong J, Song Z, Yu
X, Lu X and Lin B: Upregulated miR-193a-3p as an oncogene in
esophageal squamous cell carcinoma regulating cellular
proliferation, migration and apoptosis. Oncol Lett. 12:4779–4784.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan L, Hu F, Yan X, Wei Y, Ma W, Wang Y,
Lu S and Wang Z: Inhibition of microRNA-155 ameliorates
experimental autoimmune myocarditis by modulating Th17/Treg immune
response. J Mol Med (Berl). 94:1063–1079. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan N and Wang J: MicroRNA 34a contributes
to virus-mediated apoptosis through binding to its target gene Bax
in influenza A virus infection. Biomed Pharmacother. 83:1464–1470.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao X, Xu Y, Sun X, Ma Y, Zhang Y and
Wang Y, Guan H, Jia Z, Li Y and Wang Y: miR-17-5p promotes
proliferation and epithelial-mesenchymal transition in human
osteosarcoma cells by targeting SRC kinase signaling inhibitor 1. J
Cell Biochem. 120:5495–5504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang WT, Qi Q, Zhao P, Li CY, Yin XY and
Yan RB: miR-590-3p is a novel microRNA which suppresses
osteosarcoma progression by targeting SOX9. Biomed Pharmacother.
107:1763–1769. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu BB, Gu ZF, Ma M, Wang JY and Wang HN:
MicroRNA-590-5p suppresses the proliferation and invasion of
non-small cell lung cancer by regulating GAB1. Eur Rev Med
Pharmacol Sci. 22:5954–5963. 2018.PubMed/NCBI
|
|
15
|
Wang FF, Wang S, Xue WH and Cheng JL:
microRNA-590 suppresses the tumorigenesis and invasiveness of
non-small cell lung cancer cells by targeting ADAM9. Mol Cell
Biochem. 423:29–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ge X and Gong L: MiR-590-3p suppresses
hepatocellular carcinoma growth by targeting TEAD1. Tumour Biol.
39:10104283176959472017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shan X, Miao Y, Fan R, Qian H, Chen P, Liu
H, Yan X, Li J and Zhou F: MiR-590-5P inhibits growth of HepG2
cells via decrease of S100A10 expression and Inhibition of the Wnt
pathway. Int J Mol Sci. 14:8556–8569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong Z, Hong C, Ma B, Wang Q, Zhang X, Li
L, Wang C and Chen D: MicroRNA-126-3p inhibits the proliferation,
migration, invasion, and angiogenesis of triple negative breast
cancer cells by targeting RGS3. Oncol Rep. 42:1569–1579.
2019.PubMed/NCBI
|
|
20
|
Alcantara KMM and Garcia RL: MicroRNA-92a
promotes cell proliferation, migration and survival by directly
targeting the tumor suppressor gene NF2 in colorectal and lung
cancer cells. Oncol Rep. 41:2103–2116. 2019.PubMed/NCBI
|
|
21
|
Xiong W, Ran J, Jiang R, Guo P, Shi X, Li
H, Lv X, Li J and Chen D: miRNA-320a inhibits glioma cell invasion
and migration by directly targeting aquaporin 4. Oncol Rep.
39:1939–1947. 2018.PubMed/NCBI
|
|
22
|
Zhang X, Xu X, Ge G, Zang X, Shao M, Zou
S, Zhang Y, Mao Z, Zhang J, Mao F, et al: miR-498 inhibits the
growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep.
41:1638–1648. 2019.PubMed/NCBI
|
|
23
|
Guan H, Mei Y, Mi Y, Li C, Sun X, Zhao X,
Liu J, Cao W, Li Y and Wang Y: Downregulation of lncRNA
ANRIL suppresses growth and metastasis in human osteosarcoma
cells. Onco Targets Ther. 11:4893–4899. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guan H, Shang G, Cui Y, Liu J, Sun X, Cao
W, Wang Y and Li Y: Long noncoding RNA APTR contributes to
osteosarcoma progression through repression of miR-132-3p and
upregulation of yes-associated protein 1. J Cell Physiol.
2234:8998–9007. 2019. View Article : Google Scholar
|
|
25
|
Chen Z, Lin J, Wu S, Xu C, Chen F and
Huang Z: Up-regulated miR-548k promotes esophageal squamous cell
carcinoma progression via targeting long noncoding RNA-LET. Exp
Cell Res. 362:90–101. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao H, Diao C, Wang X, Xie Y, Liu Y, Gao
X, Han J and Li S: MiR-543 promotes migration, invasion and
epithelial-mesenchymal transition of esophageal cancer cells by
targeting phospholipase A2 Group IVA. Cell Physiol Biochem.
48:1595–1604. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Gan H, Song W, Chai D and Wu S:
MicroRNA-145 promotes esophageal cancer cells proliferation and
metastasis by targeting SMAD5. Scand J Gastroenterol. 53:769–776.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan M, Ye L, Feng X, Shi R, Sun Z, Li Z
and Liu T: MicroRNA-590-3p inhibits invasion and metastasis in
triple-negative breast cancer by targeting slug. Am J Cancer Res.
10:965–974. 2020.PubMed/NCBI
|
|
29
|
Xu Y, Han T, Zhu Y and Chen Q: miR-590-5P
inhibits the progression of tongue squamous cell carcinoma by
targeting FasL. Int J Clin Exp Pathol. 10:11880–11887.
2017.PubMed/NCBI
|
|
30
|
Yao Q, An Y, Hou W, Cao YN, Yao MF, Ma NN,
Hou L, Zhang H, Liu HJ and Zhang B: LRP6 promotes invasion and
metastasis of colorectal cancer through cytoskeleton dynamics.
Oncotarget. 8:109632–109645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma J, Lu W, Chen D, Xu B and Li Y: Role of
Wnt co-receptor LRP6 in triple negative breast cancer cell
migration and invasion. J Cell Biochem. 118:2968–2976. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hua Y, Yang Y, Li Q, He X, Zhu W, Wang J
and Gan X: Oligomerization of Frizzled and LRP5/6 protein initiates
intracellular signaling for the canonical WNT/β-catenin pathway. J
Biol Chem. 293:19710–19724. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu W and Li Y: Salinomycin suppresses LRP6
expression and inhibits both Wnt/β-catenin and mTORC1 signaling in
breast and prostate cancer cells. J Cell Biochem. 115:1799–807.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Paolillo M and Schinelli S: Extracellular
matrix alterations in metastatic processes. Int J Mol Sci.
20:49472019. View Article : Google Scholar
|
|
37
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang J, Tian XJ and Xing J: Signal
transduction pathways of EMT induced by TGF-β, SHH, and WNT and
their crosstalks. J Clin Med. 5:412016. View Article : Google Scholar
|
|
40
|
Liu X, Yun F, Shi L, Li ZH, Luo NR and Jia
YF: Roles of signaling pathways in the epithelial-mesenchymal
transition in cancer. Asian Pac J Cancer Prev. 16:6201–6206. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dong Y, Zhang Y, Kang W, Wang G, Chen H,
Higashimori A, Nakatsu G, Go M, Tong JH, Zheng S, et al: VSTM2A
suppresses colorectal cancer and antagonizes Wnt signaling receptor
LRP6. Theranostics. 9:6517–6531. 2019. View Article : Google Scholar : PubMed/NCBI
|
